Michael Biega

Panacea Pharmaceuticals, Inc. develops precision cancer therapeutic products. The company was founded by Hossein A. Ghanbari and Kasra Ghanbari in 1999 and is headquartered in Gaithersburg, MD.

Brick Management LLC (Miramar venture Partners) is a venture capital firm founded in 2001 by Bruce Hallett, Bob Holmen and Sherman Atkinson. The firm is headquartered in Corona Del Mar, California.

Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life.

Windham Venture Management LLC (Windham Venture Management) is a venture capital firm founded in 2006 by Joe Proto, Roger Fine and Adam Fine. The firm is headquartered in New York.

Cleara Biotech BV operates as a biopharmaceutical company. It specializes in identification and specific elimination of subtypes of senescent cells with targeting age related diseases and counteracting therapy resistance in late stage cancer. The company was founded by Peter de Keizer, Marco Demaria, Tobias Madl and is headquartered in Utrecht, the Netherlands.

Apollo Ventures Holding GmbH (Apollo Health Ventures) is an Independent Venture Capital firm founded in 2016 by Nils Regge and Alexandra Bause. The firm is headquartered in Hamburg.

Isterian Biotech, Inc. engages in the business of biotechnology services. The company is headquartered in Brooklyn, NY.

Cambrian Biopharma, Inc. operates as clinical-stage biopharmaceutical company. The company is headquartered in Brooklyn, NY.

Workit Health, Inc. offers online addiction treatment solutions. It provides addiction treatment with board-certified doctors, therapists, and coaches over live chat and video. The firm's services include opioid addiction treatment, recovery coaching, online therapy, assessments, and addiction courses. The company was founded by Lisa McLaughlin and Robin McIntosh in 2015 and is headquartered in Ann Arbor, MI.

Aria Health System provides health care services. It operates outpatient centers, and primary care physicians. The company was founded in 1902 and is headquartered in Philadelphia, PA.

Ovintiv Canada ULC engages in the production of natural gas, oil and natural gas liquids. It operates through the following segments: Canadian Operations, USA Operations and Market Optimization. The Canadian Operations segment includes the exploration for, development of and production of natural gas, oil and natural gas liquids and other related activities within Canada. The USA Operations segment involves in the exploration, development and production of natural gas, oil, and natural gas liquids and other related activities within the U.S. The Market Optimization segment is responsible for the sale of the company's proprietary production to third party customers and the associated netback price. The company was founded in 1881 and is headquartered in Calgary, Canada.

Part of UnitedHealth Group, Inc., Alliance Health Solutions, Inc. is a company that provides web-based healthcare management services. The company is based in Edina, MN. The company was founded by Deneen Vojta. Alliance Health Solutions was acquired by Uniprise, Inc. on March 20, 2006.

TurningPoint Healthcare Solutions LLC develops implantable devices which optimize the implant and therapeutic costs. It provides solutions to manage cost surgical procedures involving implantable devices. The company was founded by Michael Lynch and is headquartered in Lake Mary, FL.

Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington.

Aquilo Partners LP provides corporate finance, mergers & acquisitions and strategic advisory services to public and private life science companies. It also provides buyside M&A, sellside M&A, partnering and private placement. The company was founded by Brian Polzak, John Rumsey and James Zanze in 2001 and is located in San Francisco, CA.

Alvaxa Biosciences, Inc. develops camelid antibodies and nanobodies. The company was founded by Robert H. Pierce and is headquartered in Spokane, WA.

Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA.

Aeovian Pharmaceuticals, Inc. engages in the development of pharmaceuticals. It offers inhibitors for the treatment of rare and age-related diseases. The company was founded by Stelios T. Tzannis in 2012 and is headquartered in Novato, CA.

Children's Health Care engages in the operation of a children's hospital. It offers emergency and trauma care, primary care, surgery, walk-in ready care, specialty care and departments, family services, and education materials. The company was founded in 1924 and is headquartered in Minneapolis, MN.

Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX.

Samsara Therapeutics, Inc. operates as a biopharmaceutical platform company. It engages in the development and commercialization of first-in-class therapeutics for the treatment of unmet medical needs and age-related diseases. The company was founded by Sebastian Aguiar in 2018 and is headquartered in Lewes, DE.

EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.

Tilos Therapeutics, Inc. designs and develops biotechnology products such as developing new treatments for cancer, fibrosis and autoimmune disease. It develops antibody therapeutics that target key immunological pathways, with a primary focus on regulatory T cells and regulation of effector cells. The company was founded by Howard L. Weiner in 2016 and is headquartered in Lexington, MA.

Bakx Therapeutics is a company based in DE that focuses on developing more effective and precise therapeutics that utilize the mitochondrial apoptosis pathway. The American company's proprietary codynx™ drug discovery platform integrates computational and experimental capabilities to collaborate with researchers in validated biological pathways. Bakx's leading asset, partnered with Ipsen, is focused on activating the bax protein to treat cancer and age-related diseases. Bakx Therapeutics, Inc. was co-founded by world-leading researchers in apoptosis and computationally aided drug discovery. Sree Kant has been the CEO of the company since 2020.

The Belfer Center for Applied Cancer Science operates a cancer research center. The non-profit company is based in Boston, MA.

IRBM SpA is a research organization that specializes in drug discovery and development. IRBM is based in Pomezia, IT, and has subsidiaries in Italy. The Italian company produces recombinant proteins in a homogeneous state and use cyclization to pre-organize compounds for target binding. The private company uses nuclear magnetic resonance (NMR) spectroscopy to study structural biology, clinical research solutions, functional genomics, structure/activity relationships, drug discovery, macromolecule, and small-molecule analysis. The company has a screening library of over 320,000 compounds and use virtual screening and NMR to drive innovation. The company was founded in 2010 by Piero di Lorenzo, who has been the CEO since then.